Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults

S. Silberstein*, P. Tfelt-Hansen, D. W. Dodick, V. Limmroth, R. B. Lipton, J. Pascual, S. J. Wang

*此作品的通信作者

研究成果: Review article同行評審

241 引文 斯高帕斯(Scopus)

摘要

In 1991 the Clinical Trials Subcommittee of the International Headache Society (IHS) developed and published its first edition of the Guidelines on controlled trials of drugs in episodic migraine because only quality trials can form the basis for international collaboration on drug therapy, and these Guidelines would 'improve the quality of controlled clinical trials in migraine'. With the current trend for large multinational trials, there is a need for increased awareness of methodological issues in clinical trials of drugs and other treatments for chronic migraine. These Guidelines are intended to assist in the design of well-controlled clinical trials of chronic migraine in adults, and do not apply to studies in children or adolescents.

原文English
頁(從 - 到)484-495
頁數12
期刊Cephalalgia
28
發行號5
DOIs
出版狀態Published - 5月 2008

指紋

深入研究「Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults」主題。共同形成了獨特的指紋。

引用此